PORTACAVAL SHUNT IN HYPERLIPOPROTEINÆMIA

Thomas E. Starzl, Charles W. Putnam, H. Peter Chase, Kendrick A. Porter

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Abstract

A 12-year-old girl with homozygous type-II hyperlipoproteinæmia, which was refractory to medical treatment, had significant improvement in her serum lipid abnormalities during a trial of parenteral hyperalimentation. Subsequently, end-to-side portacaval shunt caused striking reduction of the serum-cholesterol and low-density (beta) lipoprotein elevations, regression or disappearance of xanthomatous skin and tendinous lesions during the 61/2 months since operation, and relief of severe cardiac symptoms apparently as resorption occurred of xanthomatous deposits in the aortic valve and around the coronary arteries. Liver biopsy at 51/2 months showed several changes, including depletion of rough endoplasmic reticulum; this finding was consistent with the possibility that the portal diversion caused the desired therapeutic effects by inhibiting synthesis of hepatic cholesterol or low-density lipoprotein.

Original languageEnglish (US)
Pages (from-to)940-944
Number of pages5
JournalThe Lancet
Volume302
Issue number7835
DOIs
StatePublished - Oct 27 1973
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'PORTACAVAL SHUNT IN HYPERLIPOPROTEINÆMIA'. Together they form a unique fingerprint.

Cite this